Table A5.

Individual SRLV prevalence in each country. Mean, 95% confidence interval, and range are provided. Data extracted from scientific literature published from 1981 to 2020.

Country	Studies	N 1	Prevalence (%)		Range (%)		Refs
			Mean	CI 95% 2	Min	Max
AFRICA
Ethiopia	2	349	3.72	2.19–6.27	1.37	5.42	[19]
Morocco	2	1072	23.32	20.89–25.94	2.78	24.80	[20,21]
Nigeria	1	267	6.74	4.31–10.40	6.74	6.74	[22]
ASIA
China	12	672	22.77	19.76–26.09	5.36	50.00	[29]
India	1	140	4.29	1.98–9.03	4.29	4.29	[24]
Iraq	1	210	12.86	8.99–18.06	12.86	12.86	[32]
Iran	1	220	34.55	28.58–41.05	34.55	34.55	[26]
Japan	4	771	0.78	0.36–1.69	0.00	1.24	[31]
Jordan	1	231	36.36	30.43–42.74	36.36	36.36	[28]
Lebanon	1	184	71.20	64.27–77.25	71.20	71.20	[33]
Pakistan	1	93	7.53	3.69–14.73	7.53	7.53	[34]
Syria	13	2890	6.02	5.21–6.95	0.00	12.20	[35]
Turkey	12	2898	35.51	33.79–37.27	0.00	68.97	[23,25,27,30]
EUROPE
Austria	1	883	9.40	7.65–11.50	9.40	9.40	[56]
Belgium	1	555	9.37	7.22–12.08	9.37	9.37	[54]
Czech Republic	1	2801	19.85	18.41–21.37	19.85	19.85	[55]
Finland	1	10,802	0.00	0.00–0.04	0.00	0.00	[45]
France	3	23,404	16.68	16.20–17.16	1.70	26.67	[41]
Germany	2	2252	28.51	26.68–30.41	0.00	28.80	[46,51]
Greece	1	143	66.43	58.35–73.65	66.43	66.43	[53]
Italy	1	682	13.64	11.26–16.42	13.64	13.64	[49]
Kosovo	6	10,544	35.19	34.28–36.10	12.92	45.93	[48]
Poland	16	19,253	14.33	13.84–14.83	0.16	54.73	[39,52]
Serbia	14	11,709	3.38	3.07–3.73	0.00	9.96	[43]
Spain	16	308,858	49.84	49.67–50.02	1.23	54.41	[11,36,37,38,40,47,50]
Switzerland	1	3866	9.00	8.14–9.94	9.00	9.00	[44]
United Kingdom	1	11,757	0.74	0.60–0.91	0.74	0.74	[42]
NORTH AMERICA
Canada	29	68,019	19.21	18.92–19.51	0.00	50.00	[57,60,62,63,66]
Mexico	1	157	7.64	4.43–12.88	7.64	7.64	[64]
United States	16	56,366	24.87	24.51–25.23	2.19	52.00	[58,59,61,65]
SOUTH AND CENTRAL AMERICA
Argentina	29	42,597	1.69	1.57–1.82	0.00	30.00	[72,73]
Brazil	6	3103	1.32	0.98–1.79	0.11	8.20	[68,69,70,71,74,75]
Cosa Rica	6	718	1.95	1.16–3.25	0.00	4.26	[67]

¹ N, number of animals tested. ² CI 95%, 95% confidence interval.